Search Login Register
Aromatase Inhibitors
Summary
Description:
Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones.
Also Known As:
Inhibitors, Aromatase
Networked: 1894
relevant articles (222 outcomes,
320 trials/studies)
for this Bio-Agent
Key Diseases for which Aromatase Inhibitors is
Relevant
-
Breast Neoplasms (Breast Cancer)
:
162 outcomes 236 studies in 1405 results
-
Neoplasms (Cancer)
:
22 outcomes 36 studies in 286 results
-
Endometriosis (Adenomyosis)
:
10 outcomes 18 studies in 62 results
-
Endometrial Neoplasms (Endometrial Cancer)
:
5 outcomes 3 studies in 26 results
-
Carcinoma (Carcinomatosis)
:
4 outcomes 10 studies in 51 results
Show All >>
Drugs Related to Aromatase Inhibitors
-
Tamoxifen
-
Hormones
-
Estrogens (Estrogen)
-
anastrozole (Arimidex)
-
letrozole (Femara)
-
exemestane (Aromasin)
-
Aromatase (CYP19)
-
Estrogen Receptor Modulators (Antiestrogen)
-
Gonadotropin-Releasing Hormone (GnRH)
-
fulvestrant (Faslodex)
Show All >>
Therapies Related to Aromatase Inhibitors
-
Drug Therapy (Chemotherapy)
-
Neoadjuvant Therapy
-
Aftercare (After-Treatment)
-
Chemoprevention
-
Ovariectomy (Oophorectomy)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.